thanks grimloq - read it again and can understand they seem to be voluntary upping safety tox data points
Biogen / Eisai - just had their second death in Aduhelm Alzheimer’s clinical trial
FDA may be rightfully spooked with the growth in RNA/DNA adverse events, PYC pre-empt assurance play may prove wise in the long term, as hopefully FDA will judge PYC lead chemistry as being safe
we’ve got a lot more program INDs to submit (2 more I hope 2023 - at least 1 more for ADOA)
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)